TCL Archive Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer January 25, 2013
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007